Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy

In the current modern era of unhealthy lifestyles, non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease and has become a serious global health problem. To date, there is no approved pharmacotherapy for the treatment of NAFLD, and necessary lifestyle changes such as weight lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaznadar, Farah, Petrovic, Ana, Khaznadar, Omar, Roguljic, Hrvoje, Bojanic, Kristina, Kuna Roguljic, Lucija, Siber, Stjepan, Smolic, Robert, Bilic-Curcic, Ines, Wu, George Y., Smolic, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607797/
https://www.ncbi.nlm.nih.gov/pubmed/37892698
http://dx.doi.org/10.3390/jcm12206561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607797/
https://www.ncbi.nlm.nih.gov/pubmed/37892698
http://dx.doi.org/10.3390/jcm12206561

Ejemplares similares